You're reading Part 5 of Coercive Care, a yearlong examination of the denial of reproductive autonomy for people with sickle ...

Sickle Cell Disease Market Size Was Valued at USD 2.40 Billion in 2023, and is Projected to Reach USD 12.38 Billion by 2032, ...

The mother of a teenager with sickle cell disease said medical treatment for the genetic blood disorder was a "postcode ...

BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, ...

Participants at the launch of National Sickle Cell Disease Strategy and National Vaccine Policy The Ministry Of Health has ...

The 65th annual Haematocon conference in Nagpur gathers over 40 international experts in haematology to discuss advancements ...

For all of its challenges, living with sickle cell has offered columnist Oluwatosin Adesoye resilience, empathy, support, and happiness.

Beam Therapeutics enrolls 35 patients in BEACON trial for BEAM-101 in sickle cell disease, with promising early safety and ...

The death, which investigators linked to a preparatory chemo treatment rather than Beam's medicine, highlights the risks of ...

About 36 Nigerians living abroad, are competing for a place on the eligibility list for the new bone marrow transplant ...

Newborn screening, comprehensive care, and disease-modifying therapies are changing the outlook for patients with sickle cell ...

PRESS RELEASEAB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE ...